Clinical and Biochemical Effects of Catecholamine Depletion on Antidepressant-Induced Remission of Depression
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Background Most hypotheses of the therapeutic mechanism of action of antidepressant drugs have focused on the role of the monoamines. We examined the effect of catecholamine depletion on antidepressant-induced remission. Method The tyrosine hydroxylase inhibitor alpha-methylparatyrosine and the antihistamine diphenhydramine hydrochloride were administered, during separate test sessions, to depressed patients in remission maintained with either norepinephrine reuptake inhibitors (desipramine [n = 7] or mazindol [n = 2]) or serotonin reuptake inhibitors (fluoxetine hydrochloride [n = 9] or sertraline hydrochloride [n = 1]). Because of considerable sedation associated with alpha-methylparatyrosine testing, diphenhydramine was used as an active control rather than an inactive placebo. The effects of alpha-methylparatyrosine and diphenhydramine on depression, anxiety, and plasma catecholamine metabolites were assessed. Results alpha-Methylparatyrosine produced similar significant decreases in plasma 3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid levels in the treatment groups. alpha-Methylparatyrosine produced a robust increase in depressive symptoms on the Hamilton Depression Rating Scale, including depressed mood, decreased concentration, anhedonia, loss of interest, and feelings of worthlessness, helplessness, and hopelessness, in the desipramine-mazindol but not in the fluoxetine-sertraline group. Diphenhydramine had no effects on mood in either treatment group.…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The serotonin deficit hypothesis explanation for major depressive disorder (MDD) has persisted among clinicians and the general public alike despite insufficient supporting evidence.”
From Beyond the serotonin deficit hypothesis: Communicating a neuroplasticity framework of major depressive disorder (2024) · cites this paper as [5]
In the citing paper
“However, the serotonin deficit hypothesis has been considered incorrect for at least the last 20 years due to insufficient evidence [4, 5].”
From Beyond the serotonin deficit hypothesis: Communicating a neuroplasticity framework of major depressive disorder (2024) · cites this paper as [5]
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
The Biochemical Basis of Neuropharmacology.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-575_2 · Cited by 1,878
Norepinephrine in Depressive Reactions: A Review
BUNNEY, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,153
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 924
Hyttel, J. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80179-6 · Cited by 584
Overview: toward a dysregulation hypothesis of depression
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.9.1017 · Cited by 518
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Cusack, B., Nelson, A., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349
Role of the dopaminergic system in depression
Kapur, S., & John Mann, J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 348
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 336
Delgado, P. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110025005 · Cited by 289
Self-citationPredictors of Drug Response in Depression
Joyce, P. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010091014 · Cited by 280
Woods, S. W. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250051007 · Cited by 265
Brady, L. S., Gold, P. W., Herkenham, M., Lynn, A. B., & Whitfield, H. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90459-m · Cited by 235
Chiodo, L. A., & Antelman, S. M. (1980) · Nature · doi:10.1038/287451a0 · Cited by 210
Delgado, P. L., Price, L. H., Miller, H. L., Salomon, R. M., Licinio, J., Krystal, J. H., Heninger, G. R., & Charney, D. S. (1991) · PubMed · Cited by 202
Self-citationNestler, E. J., McMahon, A., Sabban, E. L., Tallman, J. F., & Duman, R. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7522 · Cited by 198
Owens, M. J., & Nemeroff, C. B. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514368.ch15 · Cited by 181
Modigh, K. (1976) · Psychopharmacology · doi:10.1007/bf00427287 · Cited by 177
Biochemical and pharmacologic effects of α-methyltyrosine in man
Engelman, K., Horwitz, D., Jéquier, E., & Sjoerdsma, A. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105754 · Cited by 168
Shopsin, B., Gershon, S., Goldstein, M. N., Friedman, E., & Wilk, S. (1975) · PubMed · Cited by 157
Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments
Willner, P. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90007-3 · Cited by 154
Delgado, P. L., Miller, H., Salomon, R. M., Licinio, J., Heninger, G. R., Gelenberg, A. J., & Charney, D. S. (1993) · PubMed · Cited by 153
Self-citationSpyraki, C., & Fibiger, H. C. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90431-2 · Cited by 150
Hudson, C. J., Young, L. T., Li, P. P., & Warsh, J. J. (1993) · Synapse · doi:10.1002/syn.890130311 · Cited by 147
Studies of Alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in Depression and Mania
BUNNEY, W. E., BRODIE, H. K. H., MURPHY, D. L., & GOODWIN, F. K. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.7.872 · Cited by 136
Maas, J. W., Hattox, S. E., Landis, D. H., & Roth, R. H. (1976) · Brain Research · doi:10.1016/0006-8993(76)90854-4 · Cited by 134
Melia, K. R., Rasmussen, K., Terwilliger, R. Z., Haycock, J. W., Nestler, E. J., & Duman, R. S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09748.x · Cited by 133
Menkes, D. B., & Aghajanian, G. K. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90319-8 · Cited by 132
Charney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780370036004 · Cited by 131
Sjoerdsma, A., Engelman, K., Spector, S., & Udenfriend, S. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90062-0 · Cited by 128
Menkes, D. B., Aghajanian, G. K., & McCall, R. B. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90018-1 · Cited by 122
Brain Biogenic Amine Depletion and Mood
Mendels, J. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760100019004 · Cited by 119
(2010) · Assessment Scales in Depression, Mania and Anxiety · doi:10.4324/9780203308356_chapter_2 · Cited by 118
Klimek, V., & Nielsen, M. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90248-2 · Cited by 118
Reduced sensitivity of neurons to noradrenamine after chronic treatment with antidepressant drugs
Olpe, H. R., & Schellenberg, A. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90111-9 · Cited by 109
Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents
Heal, D. J., Akagi, H., Bowdler, J. M., & Green, A. R. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90549-5 · Cited by 109
Reliability and Validity of the Symptoms of Major Depressive Illness
Mazure, C. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800050053006 · Cited by 103
Brodie, H. K. H., Murphy, D. L., Goodwin, F. K., & Bunney, W. E. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1218 · Cited by 100
Schultz, J. E., Siggins, G. R., Schocker, F. W., Türck, M., & Bloom, F. E. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32372-4 · Cited by 89
Widerl�v, E., & Lewander, T. (1978) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495547 · Cited by 85
Charney, D. S., Heninger, G. R., & Sternberg, D. E. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.142.3.265 · Cited by 84
Scuvée‐Moreau, J., & Svensson, T. H. (1982) · Journal of Neural Transmission · doi:10.1007/bf01249278 · Cited by 82
Antidepressant drugs given repeatedly increase binding to α1-adrenoceptors in the rat cortex
Maj, J., Klimek, V., & Nowak, G. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90328-0 · Cited by 81
Lacroix, D., Blier, P., Curet, O., & de Montigny, C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24669-9 · Cited by 77
Nolen, W. A., Putte, J. J. V. D., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., & Haffmans, J. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06402.x · Cited by 74
Racagni, G., Mocchetti, I., Calderini, G., Battistella, A., & Brunello, N. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90191-0 · Cited by 73
Bacopoulos, N. G., Redmond, D. E., & Roth, R. H. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb11048.x · Cited by 72
Sugrue, M. F. (1982) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00506306 · Cited by 67
Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine
Maj, J., Rogóž, Z., Skuza, G., & Sowińska, H. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb03011.x · Cited by 66
Bauer, M. E., & Tejani-Butt, S. M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90134-u · Cited by 64
Efficacy of fluvoxamine in treatment-refractory depression
Delgado, P. L., Price, L. H., Charney, D. S., & Heninger, G. R. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90009-2 · Cited by 63
Effect of antidepressant drugs on monoamine synthesis in brain in vivo
Moret, C. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90146-g · Cited by 62
Duman, R. S., Strada, S. J., & Enna, S. J. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23460-7 · Cited by 62
Heal, D. J., Lister, S., Smith, S. L., Davies, C. L., Molyneux, S. G., & Green, A. R. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90214-9 · Cited by 61
Functional supersensitivity of CNS α1-adrenoceptors following chronic antidepressant treatment
Menkes, D. B., Kehne, J. H., Gallager, D. W., Aghajanian, G. K., & Davis, M. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90411-3 · Cited by 59
Forcada Calvo, A. (1960) · PubMed · Cited by 58
Cohen, R. M., Aulakh, C. S., Campbell, I. C., & Murphy, D. L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90614-8 · Cited by 54
Fluoxetine in tricyclic refractory major depressive disorder
Beasley, C. M., Sayler, M. E., Cunningham, G. E., Weiss, A. M., & Masica, D. N. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90144-w · Cited by 47
Melia, K. R., Nestler, E. J., & Duman, R. S. (1992) · Psychopharmacology · doi:10.1007/bf02245280 · Cited by 43
Biochemistry of Affective Disorders
Aillon, G. A. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71517-5 · Cited by 42
The Effect of Mianserin on Alpha-2 Adrenergic Receptor Function in Depressed Patients
Charney, D. S., Heninger, G. R., & Sternberg, D. E. (1984) · British Journal of Psychiatry · doi:10.1192/bjp.144.4.407 · Cited by 39
New perspectives on the molecular pharmacology of affective disorders
Sulser, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449803 · Cited by 39
Gillespie, D. D., Manier, D. H., Sanders-Bush, E., & Sulser, F. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24229-x · Cited by 38
Biegon, A. R. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02833.x · Cited by 36
MINCHIN, M. C. W., Williams, J., Bowdler, J. M., & Green, A. R. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb08044.x · Cited by 35
Garcha, G., Smokcum, R. W. J., Stephenson, J. D., & Weeramanthri, T. B. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90276-6 · Cited by 35
McManus, D. J., & Greenshaw, A. J. (1991) · Psychopharmacology · doi:10.1007/bf02244204 · Cited by 29
DAVIS, M., & Menkes, D. B. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09288.x · Cited by 28
Do antidepressants induce dopamine autoreceptor subsensitivity?
Macneil, D. A., & GOWER, M. (1982) · Nature · doi:10.1038/298302a0 · Cited by 24
Diggory, G. L., & Buckett, W. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90617-4 · Cited by 24
Hong, K. W., Rhim, B. Y., & Lee, W. S. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90468-1 · Cited by 23
McKenna, K. F., Baker, G. B., Coutts, R. T., & Greenshaw, A. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810823 · Cited by 19
Effects of isoproterenol in panic disorder patients after antidepressant treatment
Pohl, R. B., Yeragani, V. K., & Balon, R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90575-m · Cited by 18
Repeated treatment with antidepressant drugs prevents salbutamol-induced hypoactivity in rats
Przegaliński, E., Baran, L., Siwanowicz, J., & Bigajska, K. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80004-0 · Cited by 17
Psychobiological and pharmacological studies of manic-depressive illness
Bunney, W. E., Gershon, E. S., Murphy, D. L., & Goodwin, F. K. (1972) · Journal of Psychiatric Research · doi:10.1016/0022-3956(72)90021-0 · Cited by 17
Do antidepressants induce dopamine autoreceptor subsensitivity? (reply)
Chiodo, L. A., & Antelman, S. M. (1982) · Nature · doi:10.1038/298302b0 · Cited by 7
Sapena, R., Morin, D., Zini, R., & Tillement, J. P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90369-t · Cited by 7
Gleiter, C., & Nutt, D. (1988) · Psychopharmacology · doi:10.1007/bf00216075 · Cited by 5
Antkiewicz‐Michaluk, L., Rokosz-Pelc, A., & Vetulani, J. (1985) · PubMed · Cited by 4
The dissociation of neuroleptic induced motivational and motor impairments
Willner, P., Towell, A., & Muscat, R. A. (1986) · Psychopharmacology · Cited by 2
Cited by
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model
Pizzagalli, D. A. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185606 · Cited by 1,155
“Miller et al. (1996) reported that administration of a tyrosine hydroxylase inhibitor [α-methylparatyrosine (AMPT)] increased depressive (including anhedonic) symptoms in remitted subjects.”
BackgroundDiscovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
“Among untreated, symptomatic depressed patients prior to initiation of an antidepressant treatment CD failed to exacerbate depression (Miller et al, 1996b).”
BackgroundSelf-citationThe chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959
“…decreases transmission at 5HT synapses (Delgado et al., 1990, 1999), while the effect in patients treated with specific NA reuptake inhibitors (NRIs) is blocked by a pharmacological intervention that decreases transmission at catecholaminergic synapses (Delgado et al., 1993; Miller et al., 1996).”
Background
Metadata
- Authors
- Miller, H. L.
- Affiliations
- Yale University (US)
- Corresponding author
- Miller, Heien L.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-02-01
- Volume
- 53
- Issue
- 2
- Pages
- 117
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2127017530
- Cited by
- 192
- References
- 83
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 12 · 2012: 9
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH30929)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- catecholamine depletion, alpha-methyl-p-tyrosine, diphenhydramine, antidepressant mechanism, depression remission, norepinephrine reuptake inhibitors, serotonin reuptake inhibitors, desipramine, mazindol, fluoxetine, sertraline, homovanillic acid, 3-methoxy-4-hydroxyphenylethyleneglycol, monoamine hypothesis, depression relapse
- MeSH terms
- Antidepressive Agents, Brain, Brain Chemistry, Depressive Disorder, Desipramine, Diphenhydramine, Dopamine, Fluoxetine, Humans, Mazindol, Methyltyrosines, Norepinephrine, Psychiatric Status Rating Scales, 1-Naphthylamine, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.